Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
European Journal of Obstetrics & Gynecology and Reproductive Biology（2019）
摘要
Our results suggest that long-term use of COC after GnRH agonist plus add-back therapy is comparable to dienogest as a long-term postoperative medical treatment for endometriosis.
更多查看译文
关键词
Endometriosis,Dienogest,Combined oral contraceptive,Qualityof-life,Bone mineral density
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要